preclinical
36 stories tagged "preclinical"
Vitamin B12 Rescued Worms With a Rare Childhood-Disease Mutation, and Patients Run Short of the Molecule It Helps Make
Eight Verheij syndrome patients had about 85 percent less methionine in their blood than controls, the molecule a B12-dependent enzyme regenerates. The vitamin was tested in worms, not in them.
Nutrition & FoodThe Plant Protein a Princeton Scientist Wants on Food Labels Sent a Gut-Made Toxin Up Tenfold in Fiber-Starved Mice
In Princeton's fiber-starved mice, gut bacteria leaned on protein the body secretes into the gut, likely mucus, to make p-cresol sulfate, a compound tied to kidney toxicity and worse cancer outcomes. Fiber cut it. Indigestible plant protein without fiber pushed it up roughly tenfold.
Metabolic & WeightThe 'Natural Ozempic' Going Around Again Has Never Been Tested in a Human
BRP cut food intake by up to half in mice and minipigs and stripped fat from obese mice with no sign of nausea. Its plasma half-life is under ten minutes, its receptor is unknown, and its discoverer cofounded the company taking it to people.
Brain & AgingMotor Neurons Carrying Alzheimer's Mutations Fumbled the Signal to Healthy Muscle, With No Brain Attached
Healthy muscle, mutant motor neurons, no brain or spinal cord: the nerve-to-muscle signal still faltered, and two standard Alzheimer's drugs failed to rescue it in the PSEN1 line.
Autoimmune & InflammationAn Experimental Asthma Drug Blocks a Signal That, in Fish, Guards the Gut
Zebrafish missing the 5-oxoETE receptor developed gut inflammation with no infection. A blocker of that receptor, covered by a patent application, had already been tested in monkeys.
InvestigationsBioengineered Retracted 119 Papers in October, and Taylor & Francis Answered With a 16-Month-Old Note
More than 1,000 papers in one Taylor & Francis journal carry an "under investigation" notice. The publisher has retracted 255, and nothing on the record says how the two counts connect.
Brain & AgingAlzheimer's "DNA Repair" Drug Rests on Three Mice per Group and No Memory Test
An experimental compound sold as a new Alzheimer's drug was injected into three male mice per group, and none of them took a memory test. Human dosing so far has lasted at most a week, in men aged 19 to 45.
CancerA Glioblastoma 'Breakthrough' in October: Two Cell Lines, One Chip, and a Paper From April
Brain tumor cells grown for a month in thickened fluid moved faster and kept some of the changes, but only in two lab lines, which disagreed with each other, and nothing here has touched a patient.
Metabolic & WeightSwitching Off MTCH2 Makes Fat Cells Burn Fuel, and an Obesity-Drug Maker Paid for the Mice
Delete MTCH2 and fat cells burn fuel faster, while precursor cells mostly stop maturing into fat cells. The dish work leaned on a cervical cancer line and mouse cells, every mouse was male, and Boehringer Ingelheim funded the key mouse study.
Drugs & FDAMice Trained to Spot THC Gave the THC Answer for CBN, the Sleep-Gummy Cannabinoid
Mice given CBN twice daily for five days grew tolerant and twitched once a receptor blocker cut it off. A Canopy Growth sleep trial of CBN found about 0.5 fewer awakenings a night and missed its main measure.
Brain & AgingClear Most of the Brain's Microglia and Alzheimer's Mice Sleep Two Hours More, Plaque Load Unchanged
In amyloid mice, plaque piled up while lost sleep held flat, and the sleep came back when most microglia were cleared. That is an awkward result for an industry selling plaque removal.
Nutrition & FoodMicroplastics Make Tissue-Damaging Radicals in Water, No Sunlight Required
With no light, heat or catalyst, water turned the surfaces of six common microplastics into a source of hydroxyl radicals in lab tests, and the plastics that made the most radicals ruptured the most red blood cells.
Nutrition & FoodAn Oil Mill's Soy Emulsifier Protected Salt-Fed Mice's Memory
Salt-fed mice got worse at remembering objects and lost interest in each other. A soy lipid blunted both, in a study a food-ingredient maker helped start and fund.
CancerThe Sepsis Drug Eli Lilly Withdrew in 2011 Has a Second Life in a Dish of Blood Stem Cells
Soaked in activated protein C for one hour, human blood stem cells divided less, stayed quiescent, and engrafted better after transplant. The catch: the result lives in mice, and the molecule is one Eli Lilly withdrew as a failed sepsis drug in 2011.
Infectious DiseaseThe 'Pac-Man' Enzyme That Eats Bioplastic Also Breaks Down Penicillin
Konstanz researchers pulled an enzyme from forest soil that digests an experimental bioplastic and also cuts open penicillin. The press release says every bioplastic completely degraded. The paper's carbon numbers and the intact buried films say otherwise, and nobody put the gene in a living bacteri
Brain & AgingIn Lab Tests, the Alzheimer's Fragment Labeled 'Non-Amyloidogenic' Builds Amyloid Faster Than Amyloid Beta
For decades the alpha pathway was billed as the safe way to cut the Alzheimer's precursor protein. Its leftover fragment, p3, builds fibrils in less than half the time amyloid beta needs in lab tests, forms ring-shaped pores, and turns up in plaques where a common antibody stain can't tell the two a
Brain & AgingD-Serine Helped Old Mice in the Maze and Did Nothing for Their Skin or Bones
Restoring the protein menin in one patch of hypothalamus gave 20-month-old mice thicker skin, more bone and better learning. D-serine, the amino acid now in the headline, improved only the learning, and the one trial in healthy older adults that both news stories cite gave each person a single dose
CancerThe Compound That Outsmarts Cancer's Defenses: Eight Cell Lines, a Few Mice, and a Startup
Baylor researchers say CS18 dismantles the survival switch tumors use to resist treatment. It works in eight cell lines and a handful of mice, and its inventors just incorporated a company around it.
Brain & AgingA Bendable Fiber Thinner Than Six Hairs Records, Doses, and Stimulates a Mouse Brain at Once
Silicon brain probes scar the tissue they're built to read. A soft optical fiber from Denmark records, doses, and stimulates neurons at once, in mice, with a pharma foundation and pending patents behind it.
CancerUCLA Can Grow Thousands of Cancer-Fighting Cell Doses in Six Weeks. Every Patient So Far Has Been a Mouse.
The lab put a $5,000-a-dose price on an off-the-shelf cancer therapy grown from cord blood that controlled tumors in mice with ovarian cancer and melanoma. No human has received it.
Drugs & FDAThe 'Bone-Building Switch' Is Back in the Headlines. It Was Tested in Mice, and Only Mice
A publicly funded Leipzig compound rebuilt bone in ovariectomized mice, 8 per treated group. More than a year later the same experiment is still being sold to readers as a way to keep their bones strong for life.
CancerA New Cancer 'Weapon' That Has Only Ever Slowed Tumors in Mice
Stanford's tissue-resident natural killer cells slowed melanoma and head-and-neck tumors in mice. John Sunwoo warned against reading too much into that. The coverage read plenty into it anyway.
CancerThe Cells That Heal Wounds Are Feeding Breast Cancer Its Nerves
University of Oklahoma researchers blocked the protein in mice and triple-negative tumors grew far less. In patients, all they have is a correlation and a drug, already sold for something else, that has never been tried against breast cancer.
InvestigationsKing's College London Turned Sheep's Wool Into a Bone Scaffold, and Called It a Milestone Before a Single Human Trial
The wool membrane grew more organized bone than collagen in a rat's skull. Collagen still grew more of it, the sample size never made the press release, and no one has put the material in a person.